CXCL12 and neoplasm: Evaluation of changes within the tumor microenvironment induced by CXCL12 inhibition with NOX-A12 by comparing pre- and post-treatment biopsy specimens.Safety and tolerability of NOX-A12 plus pembrolizumab.